SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011470
Filing Date
2018-05-08
Accepted
2018-05-08 07:26:51
Documents
60
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20180331.htm 10-Q 1153042
2 EX-31.1 crsp-ex311_14.htm EX-31.1 15823
3 EX-31.2 crsp-ex312_9.htm EX-31.2 15846
4 EX-32.1 crsp-ex321_12.htm EX-32.1 7756
  Complete submission text file 0001564590-18-011470.txt   6497886

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crsp-20180331.xml EX-101.INS 1644717
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20180331.xsd EX-101.SCH 49673
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20180331_cal.xml EX-101.CAL 34361
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20180331_def.xml EX-101.DEF 201787
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20180331_lab.xml EX-101.LAB 377805
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20180331_pre.xml EX-101.PRE 310101
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 18812948
SIC: 2836 Biological Products, (No Diagnostic Substances)